Objectives To investigate clinical features associated with lack of response to MTX in juvenile idiopathic arthritis associated uveitis (JIA-U).Methods Clinical records of JIA-U patients were retrospectively reviewed. Differences among variables were assessed by Mann-Whitney and chi 2 or Fisher's exact tests as appropriate. Association between predictors and requirement of a biological disease-modifying antirheumatic drug (bDMARD) was evaluated by univariate Cox regression analysis and Kaplan-Meier curves. A multivariable logistic model was applied to estimate strength of association, adjusting for potential confounders.Results Data from 99 JIA-U patients treated with MTX were analysed (82.8% female), with a mean follow up of 9.2 years and a mean age at uveitis onset of 5.7 years. In 65 patients (65.7%) at least one bDMARD to control uveitis was required. Children requiring a bDMARD for uveitis had lower age at JIA and uveitis onset, more frequent polyarticular course, higher frequency of bilateral uveitis at onset and higher prevalence of systemic steroids' use. Despite similar frequency of ocular damage at onset, MTX non-responders showed a higher percentage of ocular damage at last visit. Younger age at JIA onset, polyarticular course and a history of systemic steroids' use resulted independent factors associated to lack of response to MTX at Cox regression analysis. Kaplan-Meier curves and the multivariate model confirm the independent role of both polyarticular course and systemic steroids' use.Conclusions Younger age at JIA onset, polyarticular course and a history of systemic steroids' use are predictors of a worse response to MTX in JIA-U.

Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis / C. Mapelli, E. Miserocchi, M. Nassisi, G.B. Beretta, L. Marelli, G. Leone, A. Marino, C. Chighizola, G. Cincinelli, T. Giani, P. Nucci, F. Viola, G. Filocamo, F. Minoia, C. Agostoni, F. Baldo, L. Baselli, S. Costi, F. Di Stasio, M. Gattinara, S. Lanni, A. Petaccia, M. Rossano, F. Vianello, N. Null. - In: RHEUMATOLOGY. - ISSN 1462-0324. - (2024), pp. keae079.1-keae079.7. [Epub ahead of print] [10.1093/rheumatology/keae079]

Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis

M. Nassisi;G.B. Beretta;L. Marelli;G. Leone;C. Chighizola;G. Cincinelli;T. Giani;P. Nucci;F. Viola;G. Filocamo;C. Agostoni;F. Baldo;L. Baselli;S. Costi;
2024

Abstract

Objectives To investigate clinical features associated with lack of response to MTX in juvenile idiopathic arthritis associated uveitis (JIA-U).Methods Clinical records of JIA-U patients were retrospectively reviewed. Differences among variables were assessed by Mann-Whitney and chi 2 or Fisher's exact tests as appropriate. Association between predictors and requirement of a biological disease-modifying antirheumatic drug (bDMARD) was evaluated by univariate Cox regression analysis and Kaplan-Meier curves. A multivariable logistic model was applied to estimate strength of association, adjusting for potential confounders.Results Data from 99 JIA-U patients treated with MTX were analysed (82.8% female), with a mean follow up of 9.2 years and a mean age at uveitis onset of 5.7 years. In 65 patients (65.7%) at least one bDMARD to control uveitis was required. Children requiring a bDMARD for uveitis had lower age at JIA and uveitis onset, more frequent polyarticular course, higher frequency of bilateral uveitis at onset and higher prevalence of systemic steroids' use. Despite similar frequency of ocular damage at onset, MTX non-responders showed a higher percentage of ocular damage at last visit. Younger age at JIA onset, polyarticular course and a history of systemic steroids' use resulted independent factors associated to lack of response to MTX at Cox regression analysis. Kaplan-Meier curves and the multivariate model confirm the independent role of both polyarticular course and systemic steroids' use.Conclusions Younger age at JIA onset, polyarticular course and a history of systemic steroids' use are predictors of a worse response to MTX in JIA-U.
biologics; juvenile idiopathic arthritis; methotrexate; uveitis;
Settore MED/30 - Malattie Apparato Visivo
Settore MED/16 - Reumatologia
2024
8-feb-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
Rheumatology markers jia.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 780.72 kB
Formato Adobe PDF
780.72 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1057008
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact